 | | PRD_000270 | | Name: | 4-biphenylacetyl-CYS-(D)ARG-TYR-N-(2-phenylethyl) amide | | Formula: | C40 H49 N7 O5 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000272 | | Name: | CBZ-DEHYDRO-LEU-VAL-ARG-TYR | | Formula: | C34 H50 N7 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000275 | | Name: | Ac-DADE-F(2)Pmp-L-NH(2) | | Formula: | C32 H46 F2 N7 O15 P | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000276 | | Name: | Thrombostatin FM inhibitor [rOicPaF(p-Me)] | | Formula: | C33 H52 N9 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000280 | | Name: | HIV ENTRY INHIBITOR PIE1 | | Formula: | C80 H118 N22 O22 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000281 | | Name: | HIV ENTRY INHIBITOR PIE7 | | Formula: | C81 H110 N20 O22 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000282 | | Name: | N-acetyl-L-alpha-aspartyl-L-asparaginyl-N-[(1R)-2-carboxy-1-formylethyl]-L-leucinamide | | Formula: | C20 H33 N5 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000284 | | Name: | AC-DQMD-CHO | | Formula: | C20 H33 N5 O10 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000285 | | Name: | L-tryptophyl-L-tyrosyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-threoninamide | | Formula: | C31 H44 Cl N8 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000289 | | Name: | BETA-SECRETASE INHIBITOR OM00-3 | | Formula: | C44 H69 N7 O15 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000290 | | Name: | BETA-SECRETASE INHIBITOR OM99-2 | | Formula: | C41 H64 N8 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000293 | | Name: | INHIBITOR AC-ESMD-CHO | | Formula: | C19 H32 N4 O10 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000298 | | Name: | N-[(2R)-3-phenyl-2-{[L-prolyl-L-phenylalanyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl]amino}propyl]-L-phenylalanyl-L-valyltyrosine | | Formula: | C58 H72 N12 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000300 | | Name: | N-acetyl-L-isoleucyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-L-prolinamide | | Formula: | C22 H36 N4 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000301 | | Name: | N-(2-oxoethyl)-L-isoleucyl-L-alpha-glutamyl-N-[(1R)-2-carboxy-1-formylethyl]-L-threoninamide | | Formula: | C21 H36 N4 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000306 | | Name: | KPFS-(CH2-NH)-LQF peptidomimetic inhibitor of PfPM1 | | Formula: | C49 H77 N10 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000309 | | Name: | L-leucyl-N-(2-oxopropyl)-L-phenylalaninamide | | Formula: | C26 H31 N5 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000313 | | Name: | MeOSuc-Ala-Ala-Pro-boroIle | | Formula: | C21 H37 B N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000314 | | Name: | METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID | | Formula: | C18 H31 B N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000315 | | Name: | O-methylsuccinyl-alanyl-alanyl-prolyl-borophenylalanine | | Formula: | C24 H35 B N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000316 | | Name: | METHOXYSUCCINYL-ALA-ALA-PRO-VALINE BORONIC ACID | | Formula: | C20 H35 B N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000317 | | Name: | N-(4-methoxy-4-oxobutanoyl)-L-alanyl-L-alanyl-N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-prolinamide | | Formula: | C21 H37 B N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000318 | | Name: | N-(4-methoxy-4-oxobutanoyl)-L-alanyl-L-alanyl-N-[(1R)-1-(dihydroxyboranyl)pentyl]-L-prolinamide | | Formula: | C21 H37 B N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000319 | | Name: | methyl N-{(2S,4S,5S)-5-[(L-alanyl-L-alanyl)amino]-2-benzyl-4-hydroxy-6-phenylhexanoyl}-L-valyl-L-valinate | | Formula: | C36 H53 N5 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000324 | | Name: | 2-{(3S)-3-[(benzylsulfonyl)amino]-2-oxopiperidin-1-yl}-N-{(2S)-1-[(3R)-1-carbamimidoylpiperidin-3-yl]-3-oxopropan-2-yl}acetamide | | Formula: | C23 H34 N6 O5 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
